sharecast

{{ storiesRelated.title }}

Headline News
11 Nov
dl evotec ag pharmaceuticals medicine drugmaker generic logo 1
Evotec surges as Triton said to consider takeover

Evotec surged on Monday as it emerged that private equity firm Triton Partners is considering a takeover bid for the German drug development company after taking a near-10% stake.

11 Nov
dl prs reit the prs reit prsr real estate real estate real estate investment trusts residential reits logo 20240709 1101
PRS REIT amends agreement with adviser amid strategic review

Private rental sector-focussed new build investor PRS REIT announced an amendment to its investment advisory agreement with Sigma PRS Management, its investment adviser, on Monday.

11 Nov
dl rhi magnesita industrial products metals components logo sign
RHI Magnesita reports continued weak demand conditions

RHI Magnesita reported a steady third-quarter performance amid challenging demand conditions in an update on Monday, as it warned of softer full-year sales than previously expected.

11 Nov
dl burberry fashion luxury shop store flagship london ftse 100 min
Burberry on brink of being taken over by Italy's Moncler - report

Luxury fashion brand Burberry is reportedly on the brink of being bought by Italy’s Moncler.

11 Nov
dl syncona ltd aim financials financial services closed end investments logo 20221222
Syncona's Autolus gets FDA approval for leukaemia treatment

Life science investor Syncona announced on Monday that its portfolio company Autolus Therapeutics has received US Food and Drug Administration (FDA) approval for Aucatzyl (obe-cel), a CAR T-cell therapy developed for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL).